Molecular Therapeutics Initiative
@mti-ucb.bsky.social
Accelerating drug discovery at UC Berkeley by bridging academia and biotech to develop next-gen therapeutics for unmet medical needs.
🏆 For the third year in a row, PitchBook has ranked UC Berkeley as the world’s top university for producing venture-backed startups: 1,650 companies, 1,804 founders, and the highest number of female founders.
The MTI is proud to be part of this momentum.
#PitchBook2025 #UCBerkeley #Biotech #MTI
The MTI is proud to be part of this momentum.
#PitchBook2025 #UCBerkeley #Biotech #MTI
September 17, 2025 at 9:48 PM
🏆 For the third year in a row, PitchBook has ranked UC Berkeley as the world’s top university for producing venture-backed startups: 1,650 companies, 1,804 founders, and the highest number of female founders.
The MTI is proud to be part of this momentum.
#PitchBook2025 #UCBerkeley #Biotech #MTI
The MTI is proud to be part of this momentum.
#PitchBook2025 #UCBerkeley #Biotech #MTI
🔬 The future of biotech is female… and global.
We just wrapped up a strategic advisory session for female founders as part of a program for international entrepreneurs.
From cancer immunotherapy to non-resistant antibiotics, they’re building what’s next 🧪
#WomenInBiotech #MolecularTherapeutics
We just wrapped up a strategic advisory session for female founders as part of a program for international entrepreneurs.
From cancer immunotherapy to non-resistant antibiotics, they’re building what’s next 🧪
#WomenInBiotech #MolecularTherapeutics
September 6, 2025 at 5:27 PM
🔬 The future of biotech is female… and global.
We just wrapped up a strategic advisory session for female founders as part of a program for international entrepreneurs.
From cancer immunotherapy to non-resistant antibiotics, they’re building what’s next 🧪
#WomenInBiotech #MolecularTherapeutics
We just wrapped up a strategic advisory session for female founders as part of a program for international entrepreneurs.
From cancer immunotherapy to non-resistant antibiotics, they’re building what’s next 🧪
#WomenInBiotech #MolecularTherapeutics
🫀 Organos, a @ucberkeleyofficial.bsky.social startup from Kevin Healy’s lab, advised by MTI Executive Director Dr. Julia Schaletzky, just secured a $2M NIH SBIR Phase IIB grant!
Their platform uses engineered heart tissue + analytics to transform cardiac drug discovery.
#biotech #cardiology #NIH
Their platform uses engineered heart tissue + analytics to transform cardiac drug discovery.
#biotech #cardiology #NIH
September 3, 2025 at 11:38 PM
🫀 Organos, a @ucberkeleyofficial.bsky.social startup from Kevin Healy’s lab, advised by MTI Executive Director Dr. Julia Schaletzky, just secured a $2M NIH SBIR Phase IIB grant!
Their platform uses engineered heart tissue + analytics to transform cardiac drug discovery.
#biotech #cardiology #NIH
Their platform uses engineered heart tissue + analytics to transform cardiac drug discovery.
#biotech #cardiology #NIH
🚀 MTI & affiliate labs at @UCBerkeley welcomed teens from the Lawrence Hall Of Science’s Teen Research Program for hands‐on tours - from their first PCRs to high‐throughput compound‐screening. Big thanks to every mentor who made STEM pathways feel real!
🌟🔬 #ScienceOutreach #MTI
🌟🔬 #ScienceOutreach #MTI
August 5, 2025 at 12:33 AM
🚀 MTI & affiliate labs at @UCBerkeley welcomed teens from the Lawrence Hall Of Science’s Teen Research Program for hands‐on tours - from their first PCRs to high‐throughput compound‐screening. Big thanks to every mentor who made STEM pathways feel real!
🌟🔬 #ScienceOutreach #MTI
🌟🔬 #ScienceOutreach #MTI
Grateful to everyone who brought #BayAreaBiotechDay to life yesterday at @ucberkeleyofficial.bsky.social! It was incredible to see the energy in the room and the cutting-edge advances shared by leaders in both academia and industry. Excited to see what’s next for biotech!
July 23, 2025 at 6:12 PM
Grateful to everyone who brought #BayAreaBiotechDay to life yesterday at @ucberkeleyofficial.bsky.social! It was incredible to see the energy in the room and the cutting-edge advances shared by leaders in both academia and industry. Excited to see what’s next for biotech!
🚨 Bay Area Biotech Day hits @ucberkeleyofficial.bsky.social
next week!
Hear from leaders at Denali, Frontier, Nurix & more on the future of drug discovery.
🧬 Posters, panels & networking.
#Biotech #DrugDiscovery #UCBerkeley
next week!
Hear from leaders at Denali, Frontier, Nurix & more on the future of drug discovery.
🧬 Posters, panels & networking.
#Biotech #DrugDiscovery #UCBerkeley
July 15, 2025 at 12:27 AM
🚨 Bay Area Biotech Day hits @ucberkeleyofficial.bsky.social
next week!
Hear from leaders at Denali, Frontier, Nurix & more on the future of drug discovery.
🧬 Posters, panels & networking.
#Biotech #DrugDiscovery #UCBerkeley
next week!
Hear from leaders at Denali, Frontier, Nurix & more on the future of drug discovery.
🧬 Posters, panels & networking.
#Biotech #DrugDiscovery #UCBerkeley
🚀 Bay Area Biotech Day lands at #UCBerkeley 7/22! Hear Nobel Laureate Carolyn Bertozzi + leaders from Denali Therapeutics, Calico Labs, Frontier Medicines & more leaders in biotechnology unveil the next wave in drug discovery. Scan the QR on the flyer to register now! 🧬🥂
June 22, 2025 at 6:07 PM
🚀 Bay Area Biotech Day lands at #UCBerkeley 7/22! Hear Nobel Laureate Carolyn Bertozzi + leaders from Denali Therapeutics, Calico Labs, Frontier Medicines & more leaders in biotechnology unveil the next wave in drug discovery. Scan the QR on the flyer to register now! 🧬🥂
Big congrats to MTI and MTx faculty member Markita Landry on winning a Guggenheim Fellowship! Her new project explores plant-based compounds from Indigenous Bolivian medicine as potential neurotherapeutics. 🌿🧠
🔗 news.berkeley.edu/2025/04/22/t...
#MTI #Neurotech #Guggenheim #UCBerkeley
🔗 news.berkeley.edu/2025/04/22/t...
#MTI #Neurotech #Guggenheim #UCBerkeley
June 14, 2025 at 2:39 AM
Big congrats to MTI and MTx faculty member Markita Landry on winning a Guggenheim Fellowship! Her new project explores plant-based compounds from Indigenous Bolivian medicine as potential neurotherapeutics. 🌿🧠
🔗 news.berkeley.edu/2025/04/22/t...
#MTI #Neurotech #Guggenheim #UCBerkeley
🔗 news.berkeley.edu/2025/04/22/t...
#MTI #Neurotech #Guggenheim #UCBerkeley
Excited to announce a new collaboration between the Molecular Therapeutics Initiative (MTI) and Amgen Inc.! This partnership includes funding for cutting-edge research & an internship program for grad students to train in drug discovery & development at Amgen.
#MTI #Amgen #Biotech #UCB
#MTI #Amgen #Biotech #UCB
June 8, 2025 at 12:27 AM
🧠 Don’t miss it!
Hardly Strictly Synapses
🗓️ June 3 | 9 - 4:30 | UC Berkeley
🎤 Südhof (Nobel), Gouaux, Chen, Gomez, and more
✨ Celebrating 1 year of Berkeley Neuro
📍 125 LKS | FREE entry
Scan flyer QR to register!
#Neuroscience #Berkeley #Synapse #NeuroTwitter
Hardly Strictly Synapses
🗓️ June 3 | 9 - 4:30 | UC Berkeley
🎤 Südhof (Nobel), Gouaux, Chen, Gomez, and more
✨ Celebrating 1 year of Berkeley Neuro
📍 125 LKS | FREE entry
Scan flyer QR to register!
#Neuroscience #Berkeley #Synapse #NeuroTwitter
May 23, 2025 at 3:16 PM
🧠 Don’t miss it!
Hardly Strictly Synapses
🗓️ June 3 | 9 - 4:30 | UC Berkeley
🎤 Südhof (Nobel), Gouaux, Chen, Gomez, and more
✨ Celebrating 1 year of Berkeley Neuro
📍 125 LKS | FREE entry
Scan flyer QR to register!
#Neuroscience #Berkeley #Synapse #NeuroTwitter
Hardly Strictly Synapses
🗓️ June 3 | 9 - 4:30 | UC Berkeley
🎤 Südhof (Nobel), Gouaux, Chen, Gomez, and more
✨ Celebrating 1 year of Berkeley Neuro
📍 125 LKS | FREE entry
Scan flyer QR to register!
#Neuroscience #Berkeley #Synapse #NeuroTwitter
🚨 Big win for Berkeley in the CRISPR patent battle:
A federal appeals court says the USPTO got it wrong - Broad’s patent claims were legally flawed. Case now heads back for reconsideration.
Dr. Jennifer Doudna, co-inventor and MTI board member, is still leading the way.
#CRISPR #MTI #UCberkeley
A federal appeals court says the USPTO got it wrong - Broad’s patent claims were legally flawed. Case now heads back for reconsideration.
Dr. Jennifer Doudna, co-inventor and MTI board member, is still leading the way.
#CRISPR #MTI #UCberkeley
May 16, 2025 at 5:38 PM
🚨 Big win for Berkeley in the CRISPR patent battle:
A federal appeals court says the USPTO got it wrong - Broad’s patent claims were legally flawed. Case now heads back for reconsideration.
Dr. Jennifer Doudna, co-inventor and MTI board member, is still leading the way.
#CRISPR #MTI #UCberkeley
A federal appeals court says the USPTO got it wrong - Broad’s patent claims were legally flawed. Case now heads back for reconsideration.
Dr. Jennifer Doudna, co-inventor and MTI board member, is still leading the way.
#CRISPR #MTI #UCberkeley
🧪 Meet 2025 MTI Innovators Rumi Sherriff & Dr. James Olzmann!
They’re developing molecular glues that coax cancer cells into degrading mutant lipid kinases - drivers in aggressive blood cancers.
From AI-driven target discovery to real biochemical action, this is next-gen translational science.
They’re developing molecular glues that coax cancer cells into degrading mutant lipid kinases - drivers in aggressive blood cancers.
From AI-driven target discovery to real biochemical action, this is next-gen translational science.
May 16, 2025 at 1:48 AM
🧪 Meet 2025 MTI Innovators Rumi Sherriff & Dr. James Olzmann!
They’re developing molecular glues that coax cancer cells into degrading mutant lipid kinases - drivers in aggressive blood cancers.
From AI-driven target discovery to real biochemical action, this is next-gen translational science.
They’re developing molecular glues that coax cancer cells into degrading mutant lipid kinases - drivers in aggressive blood cancers.
From AI-driven target discovery to real biochemical action, this is next-gen translational science.
🌍 Meet Dr. Matt Welch, 2025 MTI Innovator Awardee!
His lab is developing selective inhibitors of parasite-specific kinesins - a new and safer strategy to treat African sleeping sickness and related diseases.
A leap forward in neglected tropical disease drug discovery.
#MTI #GlobalHealth
His lab is developing selective inhibitors of parasite-specific kinesins - a new and safer strategy to treat African sleeping sickness and related diseases.
A leap forward in neglected tropical disease drug discovery.
#MTI #GlobalHealth
May 9, 2025 at 4:18 AM
🌍 Meet Dr. Matt Welch, 2025 MTI Innovator Awardee!
His lab is developing selective inhibitors of parasite-specific kinesins - a new and safer strategy to treat African sleeping sickness and related diseases.
A leap forward in neglected tropical disease drug discovery.
#MTI #GlobalHealth
His lab is developing selective inhibitors of parasite-specific kinesins - a new and safer strategy to treat African sleeping sickness and related diseases.
A leap forward in neglected tropical disease drug discovery.
#MTI #GlobalHealth
🧫 Meet Dr. Jim Hurley, 2025 MTI Innovator Awardee!
His lab is unlocking the druggable potential of the ESCRT system - an essential pathway once considered too complex to target in cancer.
From deep structural biology to novel screens, this is drug discovery done differently.
#MTI #CancerTherapeutics
His lab is unlocking the druggable potential of the ESCRT system - an essential pathway once considered too complex to target in cancer.
From deep structural biology to novel screens, this is drug discovery done differently.
#MTI #CancerTherapeutics
May 5, 2025 at 11:05 PM
🧫 Meet Dr. Jim Hurley, 2025 MTI Innovator Awardee!
His lab is unlocking the druggable potential of the ESCRT system - an essential pathway once considered too complex to target in cancer.
From deep structural biology to novel screens, this is drug discovery done differently.
#MTI #CancerTherapeutics
His lab is unlocking the druggable potential of the ESCRT system - an essential pathway once considered too complex to target in cancer.
From deep structural biology to novel screens, this is drug discovery done differently.
#MTI #CancerTherapeutics
🧠 Meet Dr. Ehud Isacoff, 2025 MTI Innovator Awardee!
His lab is using FRET-based biosensors to find compounds that fine-tune glutamate receptors - unlocking new treatments for depression, including hard-to-treat cases.
A new era of brain-targeted molecular therapeutics.
#MTI #Neurobiology #FRET
His lab is using FRET-based biosensors to find compounds that fine-tune glutamate receptors - unlocking new treatments for depression, including hard-to-treat cases.
A new era of brain-targeted molecular therapeutics.
#MTI #Neurobiology #FRET
May 3, 2025 at 12:00 AM
🧠 Meet Dr. Ehud Isacoff, 2025 MTI Innovator Awardee!
His lab is using FRET-based biosensors to find compounds that fine-tune glutamate receptors - unlocking new treatments for depression, including hard-to-treat cases.
A new era of brain-targeted molecular therapeutics.
#MTI #Neurobiology #FRET
His lab is using FRET-based biosensors to find compounds that fine-tune glutamate receptors - unlocking new treatments for depression, including hard-to-treat cases.
A new era of brain-targeted molecular therapeutics.
#MTI #Neurobiology #FRET
🧬 Meet Dr. Liana Lareau, 2025 MTI Innovator Awardee!
Her lab is using CRISPR + machine learning to reprogram RNA and silence toxic genes - offering hope for retinitis pigmentosa & beyond.
A new era of mutation-agnostic therapeutics.
#MTI #CRISPR #RNA
moleculartherapeutics.org/2025-mti-inn...
Her lab is using CRISPR + machine learning to reprogram RNA and silence toxic genes - offering hope for retinitis pigmentosa & beyond.
A new era of mutation-agnostic therapeutics.
#MTI #CRISPR #RNA
moleculartherapeutics.org/2025-mti-inn...
May 1, 2025 at 6:26 AM
🧬 Meet Dr. Liana Lareau, 2025 MTI Innovator Awardee!
Her lab is using CRISPR + machine learning to reprogram RNA and silence toxic genes - offering hope for retinitis pigmentosa & beyond.
A new era of mutation-agnostic therapeutics.
#MTI #CRISPR #RNA
moleculartherapeutics.org/2025-mti-inn...
Her lab is using CRISPR + machine learning to reprogram RNA and silence toxic genes - offering hope for retinitis pigmentosa & beyond.
A new era of mutation-agnostic therapeutics.
#MTI #CRISPR #RNA
moleculartherapeutics.org/2025-mti-inn...
🚀 Excited to announce that MTI Executive Director Julia Schaletzky and 2025 Innovator Awardee Jim Hurley will both be presenting at the UC Drug Discovery Consortium 2025 Symposium!
Learn more:
www.ucdrugdiscovery.org/2025-symposium #DrugDiscovery #MTI
Learn more:
www.ucdrugdiscovery.org/2025-symposium #DrugDiscovery #MTI
April 29, 2025 at 12:17 AM
🚀 Excited to announce that MTI Executive Director Julia Schaletzky and 2025 Innovator Awardee Jim Hurley will both be presenting at the UC Drug Discovery Consortium 2025 Symposium!
Learn more:
www.ucdrugdiscovery.org/2025-symposium #DrugDiscovery #MTI
Learn more:
www.ucdrugdiscovery.org/2025-symposium #DrugDiscovery #MTI
🧬 Announcing the 2025 Innovator Awardees!
Proud to support 6 researchers with $90K + resources.
🔬Lareau: CRISPR for retinitis pigmentosa
🧪Hurley: Cancer inhibitors
✨Sherriff & Olzmann: Molecular glues
🥼Welch: Sleeping sickness
🧫Isacoff: Fast-acting antidepressants
Advancing innovation at Berkeley
Proud to support 6 researchers with $90K + resources.
🔬Lareau: CRISPR for retinitis pigmentosa
🧪Hurley: Cancer inhibitors
✨Sherriff & Olzmann: Molecular glues
🥼Welch: Sleeping sickness
🧫Isacoff: Fast-acting antidepressants
Advancing innovation at Berkeley
April 25, 2025 at 11:20 PM
🧬 Announcing the 2025 Innovator Awardees!
Proud to support 6 researchers with $90K + resources.
🔬Lareau: CRISPR for retinitis pigmentosa
🧪Hurley: Cancer inhibitors
✨Sherriff & Olzmann: Molecular glues
🥼Welch: Sleeping sickness
🧫Isacoff: Fast-acting antidepressants
Advancing innovation at Berkeley
Proud to support 6 researchers with $90K + resources.
🔬Lareau: CRISPR for retinitis pigmentosa
🧪Hurley: Cancer inhibitors
✨Sherriff & Olzmann: Molecular glues
🥼Welch: Sleeping sickness
🧫Isacoff: Fast-acting antidepressants
Advancing innovation at Berkeley